Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients

Q: What are the key findings of this study?

High glycation gap (>0.60%) was independently associated with increased odds of Time Below Range <3.9 mmol/L ≥4% (adjusted OR 5.61, 95% CI 3.32-9.49) compared to low glycation gap (≤0.16%).

Q: What is the clinical evidence from this study?

Study design: Cross-Sectional. Population: Type 2 diabetes mellitus without cardiovascular disease (n=999). Intervention: High glycation gap (GGap >0.60%, defined as HbA1c minus CGM-derived estimated A1c) vs. Low (≤0.16%) and moderate (>0.16% to ≤0.60%) glycation gap tertiles. Primary outcome: CGM-derived hypoglycemia defined as Time Below Range <3.9 mmol/L (TBR <3.9) ≥4% (OR 5.61, 95% CI 3.32-9.49, p=<0.001).

Q: What does this research mean for the field?

A high glycation gap (>0.60%) is independently associated with significantly increased odds of continuous glucose monitoring-derived hypoglycemia (TBR <3.9 mmol/L ≥4%) in patients with type 2 diabetes. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

Q: What question did this study set out to answer?

To evaluate the association between the glycation gap and continuous glucose monitoring-based hypoglycemic indices in patients with type 2 diabetes mellitus.

Satomi Sonoda; Yosuke Okada; Tomoya Mita; Keiichi Torimoto; Kenichi Tanaka; Fumiya Sato; Naoto Katakami; Hidenori Yoshii; Keiko Nishida; Shingo Nakayamada; Ryota Ishii; Masahiko Gosho; Iichiro Shimomura; Hirotaka Watada

doi:10.1111/jdi.70403

July 29, 2026Journal of Diabetes InvestigationOpen Access

Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients

View Full Paper

Ask AI

Bookmark

Share

Key result

High glycation gap is linked to ~5.6-fold higher odds of clinically significant hypoglycemia.

OR 5.61
95% CI 3.32-9.49
P<0.001
n=999

Why the study?

Is a higher glycation gap (discrepancy between measured HbA1c and CGM-estimated A1c) associated with increased CGM-derived hypoglycemia and diabetic complications in Japanese patients with type 2 diabetes without cardiovascular disease?

Key Points

To evaluate the association between the glycation gap and continuous glucose monitoring-based hypoglycemic indices in patients with type 2 diabetes mellitus.
Analyzed baseline data from a multicenter cohort of 999 patients with type 2 diabetes mellitus without cardiovascular disease.
Calculated the glycation gap as the discrepancy between glycated hemoglobin (HbA1c) and estimated A1c from continuous glucose monitoring, dividing participants into low (≤0.16), moderate (>0.16 to ≤0.60), and high (>0.60) tertile groups.
Time below range <3.9 mmol/L was 3.58 ± 5.99% in the high glycation gap group versus 1.81 ± 3.62% in the moderate and 1.06 ± 3.75% in the low group (P < 0.001).
Time below range <3.0 mmol/L was 0.55 ± 2.09% in the high group compared with 0.20 ± 0.78% in the moderate and 0.23 ± 1.38% in the low group (P < 0.001), while low blood glucose index was 2.11 ± 1.96 versus 1.51 ± 1.30 and 1.04 ± 1.49 (P < 0.001).
Receiver operating characteristic curve analysis identified a glycation gap cutoff of 0.36% for achieving time below range <3.9 mmol/L <4% (AUC 0.70; 95% CI: 0.66–0.74) and 0.39% for time below range <3.0 mmol/L <1% (AUC 0.65; 95% CI: 0.59–0.89).

Study Design

Type

Cross-Sectional (n=999)

Blinding

Blinded CGM system used to prevent participants from altering behavior

Multicenter

Yes

Structured PICO

Is a higher glycation gap (discrepancy between measured HbA1c and CGM-estimated A1c) associated with increased CGM-derived hypoglycemia and diabetic complications in Japanese patients with type 2 diabetes without cardiovascular disease?

P

Population

999 Japanese outpatients aged 30-80 years (mean age 64.6, 39.1% female) with type 2 diabetes and stable glycemic control without prior cardiovascular disease across 34 medical facilities, evaluated cross-sectionally over an 8-day continuous glucose monitoring analysis window.

E

Exposure

High glycation gap (GGap >0.60%, where GGap = HbA1c − CGM-derived estimated A1c [eA1c]) or continuous GGap (per 0.1% increase), assessed using FreeStyle Libre Pro CGM over an 8-day analysis period.

C

Comparator

Low GGap tertile (GGap ≤0.16%, n=329) and moderate GGap tertile (GGap >0.16 to ≤0.60%, n=333).

O

Outcome

CGM-derived hypoglycemic indices over the 8-day analysis period, including Time Below Range <3.9 mmol/L (TBR <3.9) ≥4%, TBR <3.0 mmol/L ≥1%, minimum glucose level <3.9 mmol/L, minimum glucose level <3.0 mmol/L, and low blood glucose index (LBGI).surrogate

Main Result

Odds Ratio: 5.61 (95% CI 3.32–9.49)

p-value: p=<0.001

Limitations

Included only Japanese patients with T2DM, limiting generalizability across ethnic groups
Cross-sectional analysis of baseline data precludes establishing causal or temporal relationships (reverse causation possible)
CGM measurements were analyzed from a maximum of 8 days, creating a temporal mismatch with 1-2 month HbA1c
Potential discrepancies between actual blood glucose and FreeStyle Libre Pro CGM measurements, especially in the hypoglycemic range
Moderate AUC values (0.65-0.70) indicate limited discriminative ability of GGap as a single marker
Included only Japanese patients with T2DM, so GGap cutoff values may vary in other ethnic populations
Cross-sectional study design prevents establishing causal or temporal relationships between GGap and hypoglycemia (reverse causation is possible)
CGM data were analyzed from an 8-day period, which may be insufficient to evaluate overall glycemic control and creates a temporal mismatch with HbA1c
Potential inaccuracy of FreeStyle Libre Pro CGM in the hypoglycemic range
Moderate ROC AUC values (0.70 for TBR <3.9 at <4% and 0.65 for TBR <3.0 at <1%) indicate limited discriminative ability as a single marker

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

A high glycation gap (>0.60%) is strongly associated with CGM-detected hypoglycemia and diabetic retinopathy in patients with type 2 diabetes, indicating that clinicians should assess GGap before intensifying glucose-lowering therapy based solely on HbA1c.

Abstract

Background The glycation gap (GGap), defined as the discrepancy between glycated hemoglobin (HbA1c) and the value estimated from actual blood glucose level, is associated with diabetic complications, but its association with hypoglycemia remains unclear. Methods We evaluated the association between GGap and continuous glucose monitoring (CGM)‐based hypoglycemic indices in patients with type 2 diabetes mellitus (T2DM). Baseline data from a multicenter cohort of 999 T2DM patients without cardiovascular disease were analyzed. The difference between HbA1c and estimated A1c (eA1c) was defined as the GGap, and various CGM indices were compared among low (≤0.16), medium (<0.16 to ≤0.60), and high (>0.60) GGap tertile groups. Results In the high GGap group, the average blood glucose was lower, while the Time Below Range <3.9 mmol/L (TBR <3.9 ) and <3.0 mmol/L (TBR <3.0 ), and low blood glucose index (LBGI) were higher than in the low and middle GGap groups. Patients with minimum blood glucose levels of <3.9, <3.0 mmol/L, and TBR <3.9 ≥ 4%, and TBR <3.0 ≥ 1% had significantly higher GGap values. Conclusion This is the first study to show the strong association of high GGap with CGM‐based hypoglycemic indices in T2DM. To achieve diabetes treatment that effectively prevents the progression of diabetic complications, it is essential to assess the GGap of the individual patient before intensifying diabetes management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sonoda et al. (2026) conducted a cross-sectional in Type 2 diabetes mellitus without cardiovascular disease (n=999). High glycation gap (GGap >0.60%, defined as HbA1c minus CGM-derived estimated A1c) vs. Low (≤0.16%) and moderate (>0.16% to ≤0.60%) glycation gap tertiles was evaluated on CGM-derived hypoglycemia defined as Time Below Range <3.9 mmol/L (TBR <3.9) ≥4% (OR 5.61, 95% CI 3.32-9.49, p=<0.001). High glycation gap (>0.60%) was independently associated with increased odds of Time Below Range <3.9 mmol/L ≥4% (adjusted OR 5.61, 95% CI 3.32-9.49) compared to low glycation gap (≤0.16%).

synapsesocial.com/papers/6a6c477c747664a1aa73ceb5 https://doi.org/10.1111/jdi.70403

View Full Paper

Ask AI

Bookmark

Share

Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients

Key Points

Study Design

Structured PICO

Main Result

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Association of glycation gap with hypoglycemia CGM indices, diabetic complications, and quality of life in Japanese type 2 diabetes patients

Key Points

Study Design

Structured PICO

Main Result

Limitations

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading